Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) traded up 33.3% during trading on Tuesday . The company traded as high as C$0.06 and last traded at C$0.06. 313,400 shares traded hands during trading, an increase of 264% from the average session volume of 86,118 shares. The stock had previously closed at C$0.05.
Voyageur Pharmaceuticals Trading Up 44.4 %
The company’s 50-day moving average is C$0.05 and its 200-day moving average is C$0.06. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The firm has a market cap of C$9.07 million, a price-to-earnings ratio of -5.50 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- What to Know About Investing in Penny Stocks
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
